CoChat

Near‐normoglycaemic remission in African‐Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function

McFarlane, S. I., Chaiken, R. L., Hirsch, S., Harrington, P., Lebovitz, H. E., Banerji, M. A. · 2001 · Diabetic Medicine
Cited by 111

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

SUMMARY Aims To prospectively determine the frequency of remission and possible mechanism of beta cell recovery in non‐Whites with Type 2 diabetes mellitus in the setting of intensive glycaemic regulation using pharmacological agents. Methods Twenty‐six consecutive, newly diagnosed African‐American, Type 2 diabetic patients presenting primarily for severe hyperglycaemia (31.0 ± 12.8 mmol/l) were followed for at least 1 year. Initial hospitalization included treatment with insulin, fluids and electrolytes. Outpatient intensive glycaemic regulation included insulin or glibenclamide, diabetes education and diet that altered nutrient content. Plasma glucose and C‐peptide responses to an oral glucose tolerance test and HbA 1c were measured at < 14, 15–56 and 57–112 days after presentation. Remission was defined as a HbA 1c ≤ 6.3% and fasting plasma glucose < 6.9 mmol/l, 3 months after discontinuing all pharmacological agents. Results Eleven of 26 patients (42.3%) developed remission after a mean of 83 days of pharmacological treatment and remained in remission during follow‐up for 248–479 days; one relapsed after 294 days. Fifteen patients who did not develop a remission and were followed for 168–468 days, required continuing pharmacological therapy to be well‐controlled. (mean HbA 1c = 7.1%). There was no significant difference in age, sex, plasma glucose at presentation, initial glycaemic regulation, final body mass index, magnitude of weight change or pharmacological agents used for treatment between the two groups. Plasma C‐peptide response to oral glucose was initially (< 14 days) suppressed in all subjects and subsequently increased. The increase was significantly greater in those who underwent a remission than those who did not. Neither significant weight loss nor severe hypoglycaemia was observed in either group during intensive treatment. Conclusions Forty‐two per cent of newly diagnosed, unselected African‐Americans with Type 2 diabetes, treated intensively using pharmacological agents, education and diet developed near‐normoglycaemic remission. Remission was associated with a greater recovery of glucose‐stimulated insulin secretion suggesting that therapies directed at promoting beta cell recovery and preservation are potentially useful approaches to the treatment of Type 2 diabetes mellitus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2001.00395.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 111

Metadata

Authors
McFarlane, S. I., Chaiken, R. L., Hirsch, S., Harrington, P., Lebovitz, H. E., & Banerji, M. A.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2001-01
Volume
18
Issue
1
Pages
10-16
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2146975696
Cited by
111
References
6
FWCI
3.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Near‐normoglycaemic remission in African‐Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. https://app.cochat.ai/papers/10.1046/j.1464-5491.2001.00395.x
The paper
McFarlane, S. I., Chaiken, R. L., Hirsch, S., Harrington, P., Lebovitz, H. E., & Banerji, M. A. (2001). Near‐normoglycaemic remission in African‐Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2001.00395.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.